Title | Type | ![]() |
H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Blood Cancer Journal![]() | journal | 3.221 Q1 | 76 | 196 | 348 | 6374 | 2517 | 221 | 6.51 | 32.52 | 41.75 | ![]() |
2 | OncoImmunology![]() | journal | 2.096 Q1 | 114 | 239 | 908 | 11415 | 7088 | 885 | 7.10 | 47.76 | 43.49 | ![]() |
3 | Oncologist![]() | journal | 1.813 Q1 | 189 | 460 | 1103 | 13809 | 6228 | 942 | 5.34 | 30.02 | 43.72 | ![]() |
4 | JNCI Cancer Spectrum![]() | journal | 1.773 Q1 | 33 | 165 | 226 | 6417 | 972 | 199 | 4.35 | 38.89 | 49.42 | ![]() |
5 | JACC: CardioOncology![]() | journal | 1.687 Q1 | 34 | 113 | 178 | 3006 | 558 | 98 | 3.13 | 26.60 | 37.30 | ![]() |
6 | Cancer Science![]() | journal | 1.587 Q1 | 166 | 449 | 1152 | 18678 | 7692 | 1146 | 6.41 | 41.60 | 26.53 | ![]() |
7 | Therapeutic Advances in Medical Oncology![]() | journal | 1.488 Q1 | 68 | 162 | 416 | 7695 | 2516 | 401 | 5.17 | 47.50 | 43.65 | ![]() |
8 | Open Forum Infectious Diseases![]() | journal | 1.317 Q1 | 66 | 657 | 1424 | 19029 | 5589 | 1389 | 3.97 | 28.96 | 46.97 | ![]() |
9 | Journal of global oncology![]() | journal | 1.313 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
10 | JCO Global Oncology![]() | journal | 1.302 Q1 | 39 | 193 | 616 | 6350 | 2076 | 547 | 3.77 | 32.90 | 42.15 | ![]() |
11 | Breast![]() | journal | 1.162 Q1 | 98 | 167 | 497 | 6088 | 2088 | 459 | 3.86 | 36.46 | 50.00 | ![]() |
12 | Translational Oncology![]() | journal | 1.060 Q2 | 72 | 353 | 510 | 18268 | 2428 | 508 | 4.79 | 51.75 | 39.50 | ![]() |
13 | Oncotarget![]() | journal | 0.966 Q2 | 177 | 254 | 4184 | 10250 | 15546 | 3895 | 2.72 | 40.35 | 41.93 | ![]() |
14 | Cancer Nanotechnology![]() | journal | 0.921 Q2 | 36 | 33 | 37 | 2004 | 295 | 35 | 7.46 | 60.73 | 46.78 | ![]() |
15 | Journal of Oncology (discontinued)![]() | journal | 0.916 Q2 | 68 | 440 | 501 | 18231 | 2180 | 491 | 4.42 | 41.43 | 43.57 | ![]() |
16 | Cancer Biology and Therapy![]() | journal | 0.888 Q2 | 130 | 62 | 442 | 3198 | 1951 | 437 | 4.33 | 51.58 | 34.35 | ![]() |
17 | Advances in Radiation Oncology![]() | journal | 0.860 Q2 | 36 | 215 | 407 | 5660 | 1256 | 371 | 3.12 | 26.33 | 34.63 | ![]() |
18 | World Journal of Gastrointestinal Oncology![]() | journal | 0.761 Q2 | 42 | 156 | 271 | 11041 | 970 | 262 | 3.49 | 70.78 | 37.20 | ![]() |
19 | Sarcoma![]() | journal | 0.715 Q2 | 53 | 25 | 96 | 785 | 299 | 96 | 2.92 | 31.40 | 31.15 | ![]() |
20 | JTO Clinical and Research Reports![]() | journal | 0.674 Q3 | 18 | 126 | 65 | 2850 | 107 | 61 | 1.65 | 22.62 | 36.03 | ![]() |
21 | Integrative Cancer Therapies![]() | journal | 0.642 Q3 | 71 | 108 | 377 | 4450 | 1340 | 361 | 3.06 | 41.20 | 50.60 | ![]() |
22 | Cancer Control![]() | journal | 0.586 Q3 | 80 | 144 | 219 | 6123 | 657 | 211 | 2.21 | 42.52 | 44.88 | ![]() |
23 | Technology in Cancer Research and Treatment![]() | journal | 0.561 Q3 | 72 | 283 | 619 | 10593 | 1797 | 610 | 2.56 | 37.43 | 38.53 | ![]() |
24 | Current Urology![]() | journal | 0.476 Q3 | 21 | 59 | 116 | 991 | 236 | 116 | 1.90 | 16.80 | 21.36 | ![]() |
25 | International Journal of Surgical Oncology![]() | journal | 0.393 Q3 | 30 | 13 | 25 | 381 | 54 | 25 | 1.26 | 29.31 | 32.89 | ![]() |
26 | Journal of Immunotherapy and Precision Oncology![]() | journal | 0.272 Q4 | 9 | 32 | 68 | 1243 | 66 | 52 | 0.73 | 38.84 | 44.92 | ![]() |
27 | Recent Results in Cancer Research![]() | book series | 0.130 Q4 | 63 | 32 | 115 | 2650 | 376 | 1 | 1.67 | 82.81 | 0.00 | ![]() |
28 | Current Problems in Cancer: Case Reports![]() | journal | 4 | 84 | 0 | 1426 | 0 | 0 | 0.00 | 16.98 | 41.63 | ![]() | |
29 | Immuno-Oncology and Technology![]() | journal | 10 | 9 | 24 | 601 | 56 | 18 | 2.33 | 66.78 | 23.81 | ![]() | |
30 | MedComm![]() | journal | 25 | 51 | 38 | 6578 | 91 | 29 | 2.39 | 128.98 | 43.62 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®